2025-08-12

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191456)
(2025-08-11, After Market Close):

- Revenue +25% YoY (vs +11.8% in previous quarter and historical rate +31.7%)
- EBITDA margin -45.0% increased compared to -68.8% same period last year
- Net Debt decreased by $30 mln over the past reporting period (40.2% of market cap)
- FCF (LTM) +$0 bln (positive), 21.5% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2025-08-12

#reports #QRHC

[Quest Resource Corporation](https://eninvs.com/all.php?name=QRHC) (Waste Management) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191452)
(2025-08-11, After Market Close):

- Revenue -17.8% YoY (vs -6.8% in previous quarter and historical rate +12.4%)
- EBITDA -50% YoY (vs -250.0% in previous quarter)
- EBITDA margin 3.3% decreased compared to 5.5% same period last year
- Net Debt decreased by $3 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$70.9 bln (positive), 173543.3% of market cap
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-08-12

#reports #PUBM

[PubMatic, Inc.](https://eninvs.com/all.php?name=PUBM) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191451)
(2025-08-11, After Market Close):

- Revenue +6% YoY (vs -4.5% in previous quarter and historical rate +5.5%)
- EBITDA -14.3% YoY (vs -100.0% in previous quarter and historical rate +3.4%)
- EBITDA margin 8.5% decreased compared to 10.4% same period last year
- Net Debt increased by $27 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0 bln (negative), 8.6% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 1.5x

------------------------------------------------

2025-08-12

#reports #OMI

[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191447)
(2025-08-11, Before Market Open):

- Revenue -74.5% YoY (vs +0.7% in previous quarter and historical rate -3.4%)
- EBITDA -76.2% YoY (vs -27.4% in previous quarter and historical rate -17.7%)
- EBITDA margin 2.9% decreased compared to 3.1% same period last year
- Net Debt decreased by $192 mln over the past reporting period (65.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.9% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -16.5% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #NGS

[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191446)
(2025-08-11, After Market Close):

- Revenue +7.9% YoY (vs +10.8% in previous quarter and historical rate +38.6%)
- EBITDA +18.8% YoY (vs +12.5% in previous quarter and historical rate +65.8%)
- EBITDA margin 46.3% increased compared to 42.1% same period last year
- Net Debt increased by $16 mln over the past reporting period (5.1% of market cap)
- FCF (LTM) -$0 bln (negative), 7.3% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.5x

------------------------------------------------

2025-08-12

#reports #MRCY

[Mercury Systems](https://eninvs.com/all.php?name=MRCY) (Aerospace and Defense) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191443)
(2025-08-11, After Market Close):

- Revenue -56.5% YoY (vs +1.4% in previous quarter and historical rate +5.0%)
- EBITDA margin 16.1% increased compared to -5.7% same period last year
- Net Debt decreased by $42 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 54.4x compared to historical level (75th percentile) of 34.6x
- EV/Sales multiple is 3.8x

------------------------------------------------

2025-08-12

#reports #MNDY

[monday.com Ltd.](https://eninvs.com/all.php?name=MNDY) (Software — Application) reported for 2025 q2
(2025-08-11, Before Market Open):

- Revenue +26.7% YoY (vs +30.0% in previous quarter and historical rate +39.7%)
- EBITDA -500% YoY (vs +1200.0% in previous quarter and historical rate +50.0%)
- EBITDA margin -2.7% decreased compared to 0.8% same period last year
- Net Debt decreased by $58 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.2% of market cap
- EV/Sales multiple is 5.5x

At the opening of the session the share price went down -24.1% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #LPSN

[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for 2025 q2
(2025-08-11, After Market Close):

- Revenue -25% YoY (vs -23.5% in previous quarter and historical rate -14.9%)
- EBITDA margin -1.7% increased compared to -65.0% same period last year
- Net Debt increased by $23 mln over the past reporting period (21.1% of market cap)
- FCF (LTM) -$0 bln (negative), 27.5% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-08-12

#reports #GPRO

[GoPro](https://eninvs.com/all.php?name=GPRO) (Technological equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191430)
(2025-08-11, After Market Close):

- Revenue +257% YoY (vs -13.5% in previous quarter and historical rate +4.3%)
- EBITDA margin -9.3% increased compared to -24.2% same period last year
- Net Debt decreased by $12 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 41.4% of market cap
- EV/Sales multiple is 0.2x

------------------------------------------------

2025-08-12

#reports #GPRE

[Green Plains](https://eninvs.com/all.php?name=GPRE) (Specialty Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191429)
(2025-08-11, Before Market Open):

- Revenue -10.7% YoY (vs +0.8% in previous quarter and historical rate -8.8%)
- EBITDA -125% YoY (vs -4100.0% in previous quarter)
- EBITDA margin -0.2% decreased compared to 0.6% same period last year
- Net Debt decreased by $82 mln over the past reporting period (14.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.4% of market cap
- EV/EBITDA multiple is 21.8x compared to historical level (75th percentile) of 77.7x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +9.7% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q2
(2025-08-11, After Market Close):

- Revenue 0% YoY (vs -11.8% in previous quarter and historical rate -1.7%)
- EBITDA margin -100.0% increased compared to -127.8% same period last year
- Net Debt decreased by $12 mln over the past reporting period (8.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 63.5% of market cap
- EV/Sales multiple is -0.1x

------------------------------------------------

2025-08-12

#reports #EE

[Excelerate Energy, Inc.](https://eninvs.com/all.php?name=EE) (Utilities — Renewable) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191424)
(2025-08-11, Before Market Open):

- Revenue +12% YoY (vs +57.5% in previous quarter and historical rate -16.6%)
- EBITDA -13.7% YoY (vs +27.9% in previous quarter and historical rate +20.5%)
- EBITDA margin 33.7% decreased compared to 43.7% same period last year
- Net Debt increased by $1 bln since the start of the year (40.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 5.2x

At the opening of the session the share price went up +0.1% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #DDD

[3D Systems Corporation](https://eninvs.com/all.php?name=DDD) (3D printing services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191422)
(2025-08-11, After Market Close):

- Revenue -15.9% YoY (vs -7.8% in previous quarter and historical rate -10.6%)
- EBITDA margin -12.6% increased compared to -15.9% same period last year
- Net Debt decreased by $73 mln over the past reporting period (31.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 25.7% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 2.4x
- EV/Sales multiple is 0.7x

------------------------------------------------

2025-08-12

#reports #CEVA

[CEVA](https://eninvs.com/all.php?name=CEVA) (Wireless and intelligent sensor platforms licensor ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191420)
(2025-08-11, Before Market Open):

- Revenue -7.1% YoY (vs +9.1% in previous quarter and historical rate -6.1%)
- EBITDA margin -15.4% decreased compared to 3.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.2% of market cap)
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +7.3% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #CE

[Celanese](https://eninvs.com/all.php?name=CE) (Chemicals manufacturer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191419)
(2025-08-11, After Market Close):

- Revenue -4.5% YoY (vs -8.5% in previous quarter and historical rate +1.7%)
- EBITDA -6.8% YoY (vs -19.9% in previous quarter and historical rate -18.4%)
- EBITDA margin 12.9% decreased compared to 13.2% same period last year
- Net Debt decreased by $55 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.6% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2025-08-12

#reports #BW

[Babcock & Wilcox Enterprises](https://eninvs.com/all.php?name=BW) (Specialty Industrial Machinery) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191417)
(2025-08-11, After Market Close):

- Revenue -38.5% YoY (vs -13.0% in previous quarter and historical rate +18.7%)
- EBITDA -81.4% YoY (vs +20.0% in previous quarter)
- EBITDA margin 5.6% decreased compared to 18.4% same period last year
- Net Debt decreased by $20 mln over the past reporting period (17.7% of market cap)
- FCF (LTM) -$0.2 bln (negative), 183.6% of market cap
- EV/EBITDA multiple is 85.7x compared to historical level (75th percentile) of 55.2x
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-08-12

#reports #ASRT

[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191416)
(2025-08-11, After Market Close):

- Revenue -6.5% YoY (vs -18.8% in previous quarter and historical rate +7.8%)
- EBITDA -66.7% YoY (vs -500.0% in previous quarter and historical rate -46.5%)
- EBITDA margin 3.4% decreased compared to 9.7% same period last year
- Net Debt decreased by $11 mln over the past reporting period (31.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.8% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 3.2x
- EV/Sales multiple is -0.2x

------------------------------------------------

2025-08-12

#reports #ARIS

[Aris Water Solutions, Inc.](https://eninvs.com/all.php?name=ARIS) (Utilities — Regulated Water) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191415)
(2025-08-11, After Market Close):

- Revenue +22.8% YoY (vs +16.5% in previous quarter and historical rate +21.0%)
- EBITDA +4.5% YoY (vs +2.1% in previous quarter and historical rate +42.6%)
- EBITDA margin 37.1% decreased compared to 43.6% same period last year
- Net Debt decreased by $27 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 3.2x

------------------------------------------------

2025-08-12

#reports #AMC

[AMC Entertainment](https://eninvs.com/all.php?name=AMC) (Entertainment) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191412)
(2025-08-11, After Market Close):

- Revenue +35.6% YoY (vs -9.3% in previous quarter and historical rate +10.2%)
- EBITDA +200% YoY (vs -14700.0% in previous quarter and historical rate +40.8%)
- EBITDA margin 6.7% increased compared to 3.0% same period last year
- Net Debt decreased by $73 mln over the past reporting period (40.9% of market cap)
- FCF (LTM) +$2.1 bln (positive), 1183.5% of market cap
- EV/EBITDA multiple is 57.8x compared to historical level (75th percentile) of 104.2x
- EV/Sales multiple is 1.2x

------------------------------------------------

2025-08-12

#reports #ACVA

[ACV Auctions Inc.](https://eninvs.com/all.php?name=ACVA) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191410)
(2025-08-11, After Market Close):

- Revenue +20.5% YoY (vs +25.3% in previous quarter and historical rate +20.6%)
- EBITDA margin 2.1% increased compared to -6.2% same period last year
- Net Debt increased by $57 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/Sales multiple is 2.8x

------------------------------------------------

2025-08-12

#reports #AAON

[AAON](https://eninvs.com/all.php?name=AAON) ( Heating equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191409)
(2025-08-11, Before Market Open):

- Revenue -0.6% YoY (vs +22.9% in previous quarter and historical rate +27.1%)
- EBITDA -46.3% YoY (vs -10.0% in previous quarter and historical rate +45.1%)
- EBITDA margin 14.1% decreased compared to 26.1% same period last year
- Net Debt increased by $65 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.3% of market cap
- EV/EBITDA multiple is 27.2x compared to historical level (75th percentile) of 32.1x
- EV/Sales multiple is 4.9x

At the opening of the session the share price went down -22.5% vs S&P500 0.0%

------------------------------------------------

2025-08-12

#reports #PLUG
@ renewable-energy

[Plug Power](https://eninvs.com/all.php?name=PLUG) (Handling equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191449)
(2025-08-11, After Market Close):

- Revenue +21.7% YoY (vs +11.7% in previous quarter and historical rate +9.5%)
- EBITDA margin -94.3% increased compared to -162.2% same period last year
- Net Debt increased by $357 mln over the past reporting period (23.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 26.8% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-08-09

#reports #VERI

[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191327)
(2025-08-07, After Market Close):

- Revenue -22.6% YoY (vs -31.3% in previous quarter and historical rate -10.5%)
- EBITDA margin -50.0% decreased compared to -35.5% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 2.6x

At the opening of the session the share price went up +9.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #UFPT

[UFP Technologies](https://eninvs.com/all.php?name=UFPT) (Medical Devices) reported for 2025 q2
(2025-08-04, After Market Close):

- Revenue +37.3% YoY (vs +41.0% in previous quarter and historical rate +32.8%)
- EBITDA +30% YoY (vs +36.8% in previous quarter and historical rate +49.4%)
- EBITDA margin 17.2% decreased compared to 18.2% same period last year
- Net Debt decreased by $20 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.5% of market cap
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 26.4x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +2.1% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #TRGP

[Targa Resources](https://eninvs.com/all.php?name=TRGP) (Energy services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191314)
(2025-08-07, Before Market Open):

- Revenue +19.6% YoY (vs 0.0% in previous quarter and historical rate -6.7%)
- EBITDA +44.6% YoY (vs -6.6% in previous quarter and historical rate +64.8%)
- EBITDA margin 33.1% increased compared to 27.4% same period last year
- Net Debt increased by $874 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.1% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 3.2x

At the opening of the session the share price went up +2.0% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #SKX

[Skechers U.S.A.](https://eninvs.com/all.php?name=SKX) (Shoe seller) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191305)
(2025-07-28, After Market Close):

- Revenue +13.1% YoY (vs +7.1% in previous quarter and historical rate +11.1%)
- EBITDA +31.7% YoY (vs -10.8% in previous quarter and historical rate +27.1%)
- EBITDA margin 11.2% increased compared to 9.6% same period last year
- Net Debt decreased by $251 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0.9 bln (negative), 9.2% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 1.1x

------------------------------------------------

2025-08-09

#reports #RXST

[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191372)
(2025-08-07, After Market Close):

- Revenue -2.9% YoY (vs +26.7% in previous quarter and historical rate +67.6%)
- EBITDA margin -38.2% decreased compared to -25.7% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.5% of market cap
- EV/Sales multiple is -0.1x

At the opening of the session the share price went down -4.4% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #PRCT

[PROCEPT BioRobotics Corporation](https://eninvs.com/all.php?name=PRCT) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191397)
(2025-08-06, After Market Close):

- Revenue +49.1% YoY (vs +53.3% in previous quarter and historical rate +75.1%)
- EBITDA margin -26.6% increased compared to -49.1% same period last year
- Net Debt increased by $13 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.2% of market cap
- EV/Sales multiple is 5.4x

At the opening of the session the share price went down -8.1% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #PKOH

[Park-Ohio](https://eninvs.com/all.php?name=PKOH) (Specialty Industrial Machinery) reported for 2025 q2
(2025-08-07, After Market Close):

- Revenue -7.6% YoY (vs -3.1% in previous quarter and historical rate +1.1%)
- EBITDA -15.2% YoY (vs -15.6% in previous quarter and historical rate +59.5%)
- EBITDA margin 7.0% decreased compared to 7.6% same period last year
- Net Debt increased by $22 mln over the past reporting period (10.2% of market cap)
- FCF (LTM) +$0 bln (positive), 13.5% of market cap
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -0.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #OGS

[ONE Gas](https://eninvs.com/all.php?name=OGS) (Gas provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191273)
(2025-08-05, After Market Close):

- Revenue +19.8% YoY (vs +23.4% in previous quarter and historical rate +3.9%)
- EBITDA +6.3% YoY (vs +18.0% in previous quarter and historical rate +26.7%)
- EBITDA margin 35.6% decreased compared to 40.1% same period last year
- Net Debt increased by $64 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0.8 bln (negative), 18.3% of market cap
- EV/EBITDA multiple is 20.8x compared to historical level (75th percentile) of 22.7x
- EV/Sales multiple is 6.8x

At the opening of the session the share price went down -0.4% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #OB

[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191366)
(2025-05-09, Before Market Open):

- Revenue +60.3% YoY (vs +31.8% in previous quarter and historical rate +2.5%)
- EBITDA margin 0.9% increased compared to -0.9% same period last year
- Net Debt decreased by $17 mln over the past reporting period (8.0% of market cap)
- FCF (LTM) -$0.7 bln (negative), 308.5% of market cap
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -9.9% vs S&P500 +0.3%

------------------------------------------------

2025-08-09

#reports #NWN

[Northwest Natural Company](https://eninvs.com/all.php?name=NWN) (Utilities — Regulated Gas) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191269)
(2025-08-05, Before Market Open):

- Revenue +11.3% YoY (vs +14.1% in previous quarter and historical rate +10.2%)
- EBITDA +120% YoY (vs +39.9% in previous quarter and historical rate +31.0%)
- EBITDA margin 46.6% increased compared to 23.6% same period last year
- Net Debt increased by $74 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) -$0.6 bln (negative), 37.3% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 10.6x
- EV/Sales multiple is 3.2x

At the opening of the session the share price went up +1.3% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #DIBS

[1stdibs.Com, Inc.](https://eninvs.com/all.php?name=DIBS) (Internet Retail) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191354)
(2025-08-06, Before Market Open):

- Revenue 0% YoY (vs +4.5% in previous quarter and historical rate -5.0%)
- EBITDA margin -22.7% increased compared to -27.3% same period last year
- Net Debt increased by $6 mln over the past reporting period (6.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.5% of market cap
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +3.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #BVS

[Bioventus Inc.](https://eninvs.com/all.php?name=BVS) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191348)
(2025-08-06, Before Market Open):

- Revenue -2% YoY (vs -3.9% in previous quarter and historical rate +3.1%)
- EBITDA +255.6% YoY (vs 0.0% in previous quarter and historical rate +68.0%)
- EBITDA margin 43.2% increased compared to 11.9% same period last year
- Net Debt decreased by $12 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.3% of market cap
- EV/EBITDA multiple is 4.4x compared to historical level (75th percentile) of 18.8x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +5.7% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #BMBL

[Bumble Inc.](https://eninvs.com/all.php?name=BMBL) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191344)
(2025-08-06, After Market Close):

- Revenue -7.8% YoY (vs -7.8% in previous quarter and historical rate +7.5%)
- EBITDA -581.2% YoY (vs -18.2% in previous quarter and historical rate +18.3%)
- EBITDA margin -133.9% decreased compared to 25.7% same period last year
- Net Debt decreased by $174 mln over the past reporting period (21.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 24.0% of market cap
- EV/Sales multiple is 1.6x

At the opening of the session the share price went down -15.0% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #OPEN

[Opendoor Technologies](https://eninvs.com/all.php?name=OPEN) (Real Estate Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191086)
(2025-08-05, After Market Close):

- Revenue -70.6% YoY (vs -2.4% in previous quarter and historical rate -9.1%)
- EBITDA margin 0.6% increased compared to -7.2% same period last year
- Net Debt decreased by $565 mln over the past reporting period (40.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 41.1% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 80.3x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -25.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #NR

[Newpark Resources](https://eninvs.com/all.php?name=NR) (Oil and Gas Equipment and Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191265)
(2024-11-07, After Market Close):

- Revenue -62% YoY (vs -61.5% in previous quarter and historical rate -20.2%)
- EBITDA -14.3% YoY (vs 0.0% in previous quarter and historical rate +32.6%)
- EBITDA margin 26.5% increased compared to 11.7% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 6.6% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -6.1% vs S&P500 -0.1%

------------------------------------------------

2025-08-09

#reports #LPX

[Louisiana-Pacific Corporation](https://eninvs.com/all.php?name=LPX) (Building products manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191090)
(2025-08-06, Before Market Open):

- Revenue -7.2% YoY (vs 0.0% in previous quarter and historical rate -10.8%)
- EBITDA -48.4% YoY (vs -11.9% in previous quarter and historical rate +7.5%)
- EBITDA margin 15.4% decreased compared to 27.6% same period last year
- Net Debt decreased by $78 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 2.6x

At the opening of the session the share price went down -5.6% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #INTT

[inTEST Corporation](https://eninvs.com/all.php?name=INTT) (Semiconductor Equipment and Materials) reported for 2025 q2
(2025-08-06, Before Market Open):

- Revenue -17.6% YoY (vs -10.0% in previous quarter and historical rate +10.2%)
- EBITDA -50% YoY (vs -150.0% in previous quarter)
- EBITDA margin 3.6% decreased compared to 5.9% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 15.1% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +4.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #GNRC

[Generac](https://eninvs.com/all.php?name=GNRC) (Power generation equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191225)
(2025-07-30, Before Market Open):

- Revenue +6.3% YoY (vs +6.0% in previous quarter and historical rate +0.6%)
- EBITDA +10.7% YoY (vs +23.8% in previous quarter and historical rate +4.3%)
- EBITDA margin 12.6% increased compared to 12.1% same period last year
- Net Debt increased by $77 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 20.1x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +9.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #GMED

[Globus Medical](https://eninvs.com/all.php?name=GMED) (Medical equipment developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191222)
(2025-08-07, After Market Close):

- Revenue +18.3% YoY (vs -1.5% in previous quarter and historical rate +45.7%)
- EBITDA +30.1% YoY (vs +158.7% in previous quarter and historical rate +53.4%)
- EBITDA margin 19.7% increased compared to 17.9% same period last year
- Net Debt increased by $261 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) +$0.6 bln (positive), 7.4% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 30.9x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +3.6% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #EYPT

[EyePoint Pharmaceuticals](https://eninvs.com/all.php?name=EYPT) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191204)
(2025-08-06, Before Market Open):

- Revenue -44.4% YoY (vs +100.0% in previous quarter and historical rate +9.0%)
- EBITDA margin -1240.0% decreased compared to -377.8% same period last year
- Net Debt increased by $62 mln over the past reporting period (8.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/Sales multiple is 9.2x

At the opening of the session the share price went down -9.8% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #CQP

[Cheniere Energy Partners](https://eninvs.com/all.php?name=CQP) (Oil and Gas Midstream) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191176)
(2025-08-04, Before Market Open):

- Revenue +29.6% YoY (vs +30.2% in previous quarter and historical rate +1.4%)
- EBITDA +104.2% YoY (vs +142.5% in previous quarter and historical rate +53.9%)
- EBITDA margin 77.8% increased compared to 49.4% same period last year
- Net Debt decreased by $140 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 11.6x
- EV/Sales multiple is 4.2x

------------------------------------------------

2025-08-09

#reports #BKD

[Brookdale Senior Living](https://eninvs.com/all.php?name=BKD) (Medical Care Facilities) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191146)
(2025-08-06, After Market Close):

- Revenue +4.5% YoY (vs +4.0% in previous quarter and historical rate +6.5%)
- EBITDA +0.9% YoY (vs +14.8% in previous quarter and historical rate +16.1%)
- EBITDA margin 13.7% decreased compared to 14.1% same period last year
- Net Debt decreased by $57 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$1 bln (negative), 73.6% of market cap
- EV/EBITDA multiple is 14.8x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went down -5.6% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #AMRX

[Amneal Pharmaceuticals](https://eninvs.com/all.php?name=AMRX) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191121)
(2025-08-05, Before Market Open):

- Revenue +3.3% YoY (vs +5.5% in previous quarter and historical rate +13.1%)
- EBITDA +33.6% YoY (vs +136.8% in previous quarter and historical rate +56.5%)
- EBITDA margin 23.6% increased compared to 18.2% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.3% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went up +4.1% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #AHT

[Ashford Hospitality Trust](https://eninvs.com/all.php?name=AHT) (REIT — Hotel and Motel) reported for 2025 q2
(2025-02-27, After Market Close):

- Revenue -4.4% YoY (vs -8.9% in previous quarter and historical rate +3.1%)
- EBITDA -50.9% YoY (vs -48.7% in previous quarter and historical rate +18.0%)
- EBITDA margin 28.1% decreased compared to 54.7% same period last year
- Net Debt decreased by $15 mln over the past reporting period (46.7% of market cap)
- FCF (LTM) -$0 bln (negative), 115.2% of market cap
- EV/Sales multiple is -0.1x

At the opening of the session the share price went down -2.4% vs S&P500 -0.3%

------------------------------------------------

2025-08-09

#reports #AEYE

[AudioEye](https://eninvs.com/all.php?name=AEYE) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191110)
(2025-08-07, After Market Close):

- Revenue +25% YoY (vs +25.0% in previous quarter and historical rate +14.0%)
- Net Debt increased by $2 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/Sales multiple is 3.4x

At the opening of the session the share price went down -5.4% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #CACI
@ cybersecurity

[CACI International](https://eninvs.com/all.php?name=CACI) (Cyber security solutions and IT services provider) reported for [2025 q2](https://eninvs.com/press_release.php?ticker=CACI&q=2025 q2&id=769629)
(2024-08-07, After Market Close):

- Revenue +13.1% YoY (vs +11.9% in previous quarter and historical rate +11.7%)
- EBITDA +12.9% YoY (vs +39.4% in previous quarter and historical rate +16.1%)
- EBITDA margin 11.4% has not changed compared to 11.4% same period last year
- Net Debt decreased by $71 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$1.5 bln (negative), 13.8% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +1.0% vs S&P500 +1.0%

------------------------------------------------

2025-08-09

#reports #ZVIA

[Zevia PBC](https://eninvs.com/all.php?name=ZVIA) (Beverages — Non-Alcoholic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190812)
(2025-08-06, After Market Close):

- Revenue +12.5% YoY (vs -2.6% in previous quarter and historical rate -0.4%)
- EBITDA margin -2.2% increased compared to -17.5% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +4.7% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #ZETA

[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190811)
(2025-08-05, After Market Close):

- Revenue +35.1% YoY (vs +35.4% in previous quarter and historical rate +31.3%)
- EBITDA margin 3.9% increased compared to -6.1% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.0% of market cap
- EV/EBITDA multiple is 146.6x compared to historical level (75th percentile) of 3125x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +16.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #ZBRA

[Zebra Technologies](https://eninvs.com/all.php?name=ZBRA) (Mobile computer manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191075)
(2025-08-05, Before Market Open):

- Revenue +6.2% YoY (vs +11.3% in previous quarter and historical rate -1.6%)
- EBITDA +7.2% YoY (vs +16.8% in previous quarter and historical rate +21.8%)
- EBITDA margin 17.3% increased compared to 17.2% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.0% of market cap)
- EV/EBITDA multiple is 20x compared to historical level (75th percentile) of 22.9x
- EV/Sales multiple is 3.6x

At the opening of the session the share price went up +2.7% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #YELP

[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190803)
(2025-08-07, After Market Close):

- Revenue +3.6% YoY (vs +7.8% in previous quarter and historical rate +9.2%)
- EBITDA +34.7% YoY (vs +100.0% in previous quarter and historical rate +51.5%)
- EBITDA margin 17.8% increased compared to 13.7% same period last year
- Net Debt increased by $20 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -6.8% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #XRAY

[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191072)
(2025-08-07, Before Market Open):

- Revenue -4.9% YoY (vs -7.8% in previous quarter and historical rate +4.0%)
- EBITDA -214.6% YoY (vs +31.1% in previous quarter and historical rate -49.8%)
- EBITDA margin -10.0% decreased compared to 8.3% same period last year
- Net Debt increased by $68 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.8% of market cap
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +4.4% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #XPOF

[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190800)
(2025-08-07, After Market Close):

- Revenue -1.3% YoY (vs -3.7% in previous quarter and historical rate +18.6%)
- EBITDA +800% YoY (vs +8.3% in previous quarter and historical rate +12.4%)
- EBITDA margin 23.7% increased compared to 2.6% same period last year
- Net Debt decreased by $1.5 bln since the start of the year (635.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 35.8% of market cap
- EV/Sales multiple is 3.2x

At the opening of the session the share price went down -10.6% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #XPER

[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190797)
(2025-07-28, After Market Close):

- Revenue -11.7% YoY (vs -4.2% in previous quarter and historical rate -17.5%)
- EBITDA margin -7.5% increased compared to -15.8% same period last year
- Net Debt decreased by $7 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.1% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -8.6% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #XPEL

[XPEL](https://eninvs.com/all.php?name=XPEL) (Automotive surface protection products manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190794)
(2025-08-06, Before Market Open):

- Revenue +13.6% YoY (vs +15.6% in previous quarter and historical rate +15.5%)
- EBITDA 0% YoY (vs +18.2% in previous quarter and historical rate +12.6%)
- EBITDA margin 16.8% decreased compared to 19.1% same period last year
- Net Debt decreased by $25 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 31.7x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +12.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #XMTR

[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190791)
(2025-08-05, Before Market Open):

- Revenue +22.6% YoY (vs +22.8% in previous quarter and historical rate +27.7%)
- EBITDA margin -3.7% increased compared to -9.0% same period last year
- Net Debt increased by $46 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/Sales multiple is 3.6x

At the opening of the session the share price went up +24.9% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #WWW

[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190789)
(2025-08-06, Before Market Open):

- Revenue +11.5% YoY (vs +4.3% in previous quarter and historical rate -10.0%)
- EBITDA +26.2% YoY (vs +550.0% in previous quarter and historical rate +23.6%)
- EBITDA margin 11.2% increased compared to 9.9% same period last year
- Net Debt decreased by $31 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +4.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #WTTR

[Select Energy Services](https://eninvs.com/all.php?name=WTTR) (Complete water supply solution provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190785)
(2025-08-05, After Market Close):

- Revenue -0.3% YoY (vs +1.9% in previous quarter and historical rate +24.6%)
- EBITDA -1.7% YoY (vs +22.2% in previous quarter and historical rate +49.3%)
- EBITDA margin 15.9% decreased compared to 16.2% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 17.8% of market cap
- EV/EBITDA multiple is 5.1x compared to historical level (75th percentile) of 5.3x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went down -6.8% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #WRBY

[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190782)
(2025-08-07, Before Market Open):

- Revenue +13.8% YoY (vs +12.0% in previous quarter and historical rate +13.1%)
- EBITDA margin -2.3% increased compared to -4.8% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 139.4x compared to historical level (75th percentile) of 355.2x
- EV/Sales multiple is 3.4x

At the opening of the session the share price went up +11.1% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #WLKP

[Westlake Chemical Partners LP](https://eninvs.com/all.php?name=WLKP) (Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190781)
(2025-08-05, Before Market Open):

- Revenue +4.6% YoY (vs -16.5% in previous quarter and historical rate -6.1%)
- EBITDA -7.4% YoY (vs -39.8% in previous quarter and historical rate +15.0%)
- EBITDA margin 8.4% decreased compared to 9.5% same period last year
- Net Debt increased by $43 mln over the past reporting period (5.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 4.5x compared to historical level (75th percentile) of 4.4x
- EV/Sales multiple is 1.5x

------------------------------------------------

2025-08-09

#reports #WEYS

[Weyco Group](https://eninvs.com/all.php?name=WEYS) (Footwear and Accessories) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190776)
(2025-03-11, After Market Close):

- Revenue -9.4% YoY (vs -5.6% in previous quarter and historical rate -2.4%)
- EBITDA -42.9% YoY (vs -11.1% in previous quarter and historical rate +3.7%)
- EBITDA margin 6.9% decreased compared to 10.9% same period last year
- Net Debt decreased by $5 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 2.1% of market cap
- EV/EBITDA multiple is 6.4x compared to historical level (75th percentile) of 6.5x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went neutrally vs S&P500 +0.9%

------------------------------------------------

2025-08-09

#reports #WEN

[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for 2025 q2
(2025-08-08, Before Market Open):

- Revenue -1.8% YoY (vs -2.2% in previous quarter and historical rate +21.9%)
- EBITDA +8.7% YoY (vs +2.4% in previous quarter and historical rate -6.5%)
- EBITDA margin 20.0% increased compared to 18.0% same period last year
- Net Debt increased by $54 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 18.1x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went up +0.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #VTRS

[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190772)
(2025-08-07, Before Market Open):

- Revenue -5.7% YoY (vs -11.2% in previous quarter and historical rate -6.3%)
- EBITDA +73.4% YoY (vs -818.6% in previous quarter and historical rate -19.0%)
- EBITDA margin 31.2% increased compared to 17.0% same period last year
- Net Debt increased by $475 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$2.3 bln (positive), 19.6% of market cap
- EV/EBITDA multiple is 88.2x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went up +2.9% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #VRRM

[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190770)
(2025-08-06, After Market Close):

- Revenue +6.3% YoY (vs +6.2% in previous quarter and historical rate +9.7%)
- EBITDA +3.4% YoY (vs +4.9% in previous quarter and historical rate -7.9%)
- EBITDA margin 39.0% decreased compared to 40.1% same period last year
- Net Debt decreased by $52 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 18.4x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 5.1x

At the opening of the session the share price went down -0.1% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #VREX

[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190769)
(2025-08-07, After Market Close):

- Revenue -2.9% YoY (vs +3.4% in previous quarter and historical rate -1.0%)
- EBITDA -473.7% YoY (vs +116.7% in previous quarter and historical rate -20.2%)
- EBITDA margin -35.0% decreased compared to 9.1% same period last year
- Net Debt decreased by $130 mln over the past reporting period (34.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 23.1% of market cap
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +10.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #VHI

[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190767)
(2025-08-07, After Market Close):

- Revenue -1.4% YoY (vs -9.8% in previous quarter and historical rate -4.4%)
- EBITDA -55% YoY (vs +35.7% in previous quarter and historical rate +37.2%)
- EBITDA margin 5.5% decreased compared to 12.0% same period last year
- Net Debt increased by $39 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) -$0.3 bln (negative), 73.8% of market cap
- EV/EBITDA multiple is 3.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +2.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #VECO

[Veeco Instruments](https://eninvs.com/all.php?name=VECO) (Semiconductor Equipment and Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190765)
(2025-08-06, After Market Close):

- Revenue -5.7% YoY (vs -4.0% in previous quarter and historical rate +4.1%)
- EBITDA -26.1% YoY (vs -32.1% in previous quarter and historical rate -3.1%)
- EBITDA margin 10.2% decreased compared to 13.1% same period last year
- Net Debt decreased by $26 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.7% of market cap
- EV/EBITDA multiple is 16.1x compared to historical level (75th percentile) of 18.4x
- EV/Sales multiple is 1.8x

At the opening of the session the share price went up +14.0% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #VCYT

[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190762)
(2025-08-06, After Market Close):

- Revenue +14% YoY (vs +17.5% in previous quarter and historical rate +21.5%)
- EBITDA -100% YoY (vs +700.0% in previous quarter)
- Net Debt decreased by $33 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 60.2x compared to historical level (75th percentile) of 66.8x
- EV/Sales multiple is 3.9x

At the opening of the session the share price went up +8.5% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #UTI

[Universal Technical Institute](https://eninvs.com/all.php?name=UTI) (Education and Training Services) reported for 2025 q2
(2025-08-06, After Market Close):

- Revenue +15.3% YoY (vs +12.5% in previous quarter and historical rate +35.7%)
- EBITDA +22.2% YoY (vs +72.2% in previous quarter and historical rate +56.7%)
- EBITDA margin 10.8% increased compared to 10.2% same period last year
- Net Debt increased by $29 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 3.2% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -5.6% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #UEIC

[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for 2025 q2
(2025-08-07, After Market Close):

- Revenue +8.9% YoY (vs 0.0% in previous quarter and historical rate -10.3%)
- EBITDA margin 1.0% increased compared to -4.4% same period last year
- Net Debt decreased by $8 mln over the past reporting period (12.2% of market cap)
- FCF (LTM) +$0 bln (positive), 24.5% of market cap
- EV/EBITDA multiple is 34.7x compared to historical level (75th percentile) of 76.5x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -3.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #UBER

[Uber Technologies](https://eninvs.com/all.php?name=UBER) (Ride hailing services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190751)
(2025-08-06, Before Market Open):

- Revenue +18.2% YoY (vs +13.8% in previous quarter and historical rate +24.6%)
- EBITDA +66.9% YoY (vs +284.2% in previous quarter and historical rate +79.4%)
- EBITDA margin 12.9% increased compared to 9.1% same period last year
- Net Debt decreased by $24 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$5.5 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 34.8x compared to historical level (75th percentile) of 76.2x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went up +1.7% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TXG

[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190746)
(2025-08-07, After Market Close):

- Revenue +13.1% YoY (vs +9.9% in previous quarter and historical rate +9.6%)
- EBITDA margin 22.0% increased compared to -22.2% same period last year
- Net Debt decreased by $14 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.0% of market cap
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +13.2% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TWLO

[Twilio](https://eninvs.com/all.php?name=TWLO) (Communication services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190745)
(2025-08-07, After Market Close):

- Revenue +13.4% YoY (vs +11.9% in previous quarter and historical rate +12.0%)
- EBITDA +219.2% YoY (vs +1600.0% in previous quarter and historical rate +100.0%)
- EBITDA margin 6.8% increased compared to 2.4% same period last year
- Net Debt decreased by $93 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.5 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 54.8x compared to historical level (75th percentile) of 129.4x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went down -15.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TVTX

[Travere Therapeutics](https://eninvs.com/all.php?name=TVTX) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190744)
(2025-08-06, After Market Close):

- Revenue +111.1% YoY (vs +100.0% in previous quarter and historical rate +22.2%)
- EBITDA margin 0.9% increased compared to -107.4% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 2.3% of market cap
- EV/Sales multiple is 4.5x

At the opening of the session the share price went up +1.0% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #TTEC

[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190743)
(2025-08-07, After Market Close):

- Revenue -3.7% YoY (vs -7.5% in previous quarter and historical rate -3.1%)
- EBITDA margin 8.2% increased compared to -37.1% same period last year
- Net Debt decreased by $65 mln over the past reporting period (39.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.3% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +12.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TSQ

[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190740)
(2025-08-06, Before Market Open):

- Revenue -2.5% YoY (vs -1.0% in previous quarter and historical rate +0.3%)
- EBITDA margin 22.6% increased compared to -13.6% same period last year
- Net Debt decreased by $8 mln over the past reporting period (7.4% of market cap)
- FCF (LTM) +$0 bln (positive), 23.1% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +1.0% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TRUE

[TrueCar](https://eninvs.com/all.php?name=TRUE) (Internet Content and Information) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190736)
(2025-08-06, After Market Close):

- Revenue +11.9% YoY (vs +9.8% in previous quarter and historical rate +0.9%)
- EBITDA margin -10.6% increased compared to -26.2% same period last year
- Net Debt increased by $5 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 55.3% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +1.5% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #TRIP

[TripAdvisor](https://eninvs.com/all.php?name=TRIP) (Travel services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190734)
(2025-08-07, After Market Close):

- Revenue +6.4% YoY (vs +0.8% in previous quarter and historical rate +17.0%)
- EBITDA +46.4% YoY (vs -14.3% in previous quarter and historical rate +19.0%)
- EBITDA margin 15.5% increased compared to 11.3% same period last year
- Net Debt decreased by $57 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.4 bln (negative), 16.3% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 14.6x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +6.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TOST

[Toast, Inc.](https://eninvs.com/all.php?name=TOST) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190727)
(2025-08-05, After Market Close):

- Revenue +24.8% YoY (vs +24.4% in previous quarter and historical rate +36.5%)
- EBITDA +236.1% YoY (vs +8400.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 7.8% increased compared to 2.9% same period last year
- Net Debt decreased by $216 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 63.1x compared to historical level (75th percentile) of 385.2x
- EV/Sales multiple is 3.9x

At the opening of the session the share price went down -7.6% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TNDM

[Tandem Diabetes Care](https://eninvs.com/all.php?name=TNDM) (Medical equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190725)
(2025-08-06, After Market Close):

- Revenue +8.6% YoY (vs +21.9% in previous quarter and historical rate +10.4%)
- EBITDA margin -19.5% decreased compared to -11.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 13.9% of market cap
- EV/Sales multiple is 0.9x

At the opening of the session the share price went down -27.0% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #TNC

[Tennant Company](https://eninvs.com/all.php?name=TNC) (Cleaning equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190724)
(2025-08-06, After Market Close):

- Revenue -3.6% YoY (vs -6.8% in previous quarter and historical rate +5.2%)
- EBITDA -13.5% YoY (vs -33.3% in previous quarter and historical rate +26.4%)
- EBITDA margin 14.1% decreased compared to 15.7% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 11.5x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +0.8% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #TMCI

[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190722)
(2025-08-07, After Market Close):

- Revenue +6.8% YoY (vs +3.9% in previous quarter and historical rate +24.4%)
- EBITDA margin -29.8% increased compared to -43.2% same period last year
- Net Debt increased by $7 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 5.0% of market cap
- EV/Sales multiple is 1.6x

At the opening of the session the share price went down -3.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TKNO

[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190720)
(2025-08-07, After Market Close):

- Revenue 0% YoY (vs +11.1% in previous quarter and historical rate -0.9%)
- EBITDA margin -20.0% increased compared to -40.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 10.1% of market cap
- EV/Sales multiple is 3.2x

At the opening of the session the share price went up +26.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TGLS

[Tecnoglass](https://eninvs.com/all.php?name=TGLS) (Building Materials) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190717)
(2025-08-07, Before Market Open):

- Revenue +16.4% YoY (vs +15.0% in previous quarter and historical rate +21.3%)
- EBITDA +20.7% YoY (vs +42.6% in previous quarter and historical rate +50.4%)
- EBITDA margin 27.3% increased compared to 26.4% same period last year
- Net Debt increased by $19 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 3.6x

At the opening of the session the share price went up +2.4% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #TCX

[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190713)
(2025-08-07, After Market Close):

- Revenue +10.1% YoY (vs +9.2% in previous quarter and historical rate +5.6%)
- EBITDA +350% YoY (vs +900.0% in previous quarter)
- EBITDA margin 9.2% increased compared to 2.2% same period last year
- Net Debt decreased by $8 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0.3 bln (negative), 136.3% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +2.4% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #TAP

[Molson Coors Beverage](https://eninvs.com/all.php?name=TAP) (Beer maker) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190710)
(2025-08-05, Before Market Open):

- Revenue -2.6% YoY (vs -11.8% in previous quarter and historical rate +6.8%)
- EBITDA -1.7% YoY (vs -24.0% in previous quarter and historical rate +27.6%)
- EBITDA margin 20.2% increased compared to 20.0% same period last year
- Net Debt decreased by $125 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.5 bln (negative), 4.9% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +0.9% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #SUPN

[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191027)
(2025-08-05, After Market Close):

- Revenue -1.8% YoY (vs +4.2% in previous quarter and historical rate +9.8%)
- EBITDA -40% YoY (vs -21.2% in previous quarter and historical rate +30.7%)
- EBITDA margin 9.1% decreased compared to 14.9% same period last year
- Net Debt decreased by $61 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 11.3x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +4.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #STIM

[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190698)
(2025-08-05, Before Market Open):

- Revenue +137.5% YoY (vs +88.2% in previous quarter and historical rate +26.8%)
- EBITDA margin -18.4% increased compared to -50.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0 bln (negative), 31.7% of market cap
- EV/Sales multiple is 2x

At the opening of the session the share price went down -11.8% vs S&P500 +0.1%

------------------------------------------------

2025-08-09

#reports #SRDX

[Surmodics](https://eninvs.com/all.php?name=SRDX) (Medical device manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191021)
(2025-08-04, Before Market Open):

- Revenue 0% YoY (vs -12.5% in previous quarter and historical rate +11.6%)
- EBITDA margin -10.0% has not changed compared to -10.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/Sales multiple is 4.2x

At the opening of the session the share price went up +0.1% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #SMCI

[Super Micro Computer](https://eninvs.com/all.php?name=SMCI) (Computer Hardware) reported for 2025 q2
(2025-08-05, After Market Close):

- Revenue +8.5% YoY (vs +19.5% in previous quarter and historical rate +73.8%)
- EBITDA -28% YoY (vs -54.0% in previous quarter and historical rate +69.9%)
- EBITDA margin 4.4% decreased compared to 6.7% same period last year
- Net Debt decreased by $368 mln over the past reporting period (14.1% of market cap)
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -17.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #ROCK

[Gibraltar Industries](https://eninvs.com/all.php?name=ROCK) (Engineering materials and metals supplier) reported for 2025 q2
(2025-08-06, Before Market Open):

- Revenue -12.2% YoY (vs -1.0% in previous quarter and historical rate +14.3%)
- EBITDA -1.9% YoY (vs -7.9% in previous quarter and historical rate +24.2%)
- EBITDA margin 17.1% increased compared to 15.3% same period last year
- Net Debt decreased by $14 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went down -6.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #RGEN

[Repligen](https://eninvs.com/all.php?name=RGEN) (Highly innovative biotechnological technologies developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190994)
(2025-07-29, Before Market Open):

- Revenue +18.2% YoY (vs +11.9% in previous quarter and historical rate -3.4%)
- EBITDA +240% YoY (vs +92.3% in previous quarter and historical rate -30.2%)
- EBITDA margin 18.7% increased compared to 6.5% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.1% of market cap)
- EV/EBITDA multiple is 445.1x compared to historical level (75th percentile) of 125x
- EV/Sales multiple is 9.2x

At the opening of the session the share price went up +5.3% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #NTCT

[NetScout Systems](https://eninvs.com/all.php?name=NTCT) (Software provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190963)
(2025-08-07, Before Market Open):

- Revenue +6.9% YoY (vs +1.0% in previous quarter and historical rate -1.0%)
- EBITDA margin 7.5% increased compared to -253.1% same period last year
- Net Debt decreased by $43 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/EBITDA multiple is 6.3x compared to historical level (75th percentile) of 12.9x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went down -1.5% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #NKTR

[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190960)
(2025-08-07, After Market Close):

- Revenue -52.2% YoY (vs -54.5% in previous quarter and historical rate -8.2%)
- EBITDA margin -327.3% decreased compared to -208.7% same period last year
- Net Debt increased by $38 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/Sales multiple is 64.6x

At the opening of the session the share price went up +3.9% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #MSI

[Motorola Solutions](https://eninvs.com/all.php?name=MSI) (Telecom equipment supplier) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190955)
(2025-08-07, After Market Close):

- Revenue 0% YoY (vs +5.8% in previous quarter and historical rate +9.1%)
- EBITDA +0.4% YoY (vs +10.1% in previous quarter and historical rate +15.0%)
- EBITDA margin 27.8% increased compared to 27.7% same period last year
- Net Debt increased by $148 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.7 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 26.2x compared to historical level (75th percentile) of 25.4x
- EV/Sales multiple is 7.4x

At the opening of the session the share price went up +1.5% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #MATW

[Matthews International](https://eninvs.com/all.php?name=MATW) (Memorialization products manufacturer) reported for 2025 q2
(2025-08-05, After Market Close):

- Revenue -18.5% YoY (vs -9.1% in previous quarter and historical rate -2.1%)
- EBITDA +203.3% YoY (vs -8.9% in previous quarter and historical rate +1.8%)
- EBITDA margin 26.1% increased compared to 7.0% same period last year
- Net Debt decreased by $100 mln over the past reporting period (13.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 20.7x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +1.8% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2025 q2
(2025-08-07, Before Market Open):

- Revenue -9.6% YoY (vs -45.3% in previous quarter and historical rate -9.1%)
- EBITDA +80% YoY (vs -333.3% in previous quarter and historical rate -16.0%)
- EBITDA margin 52.9% increased compared to 26.6% same period last year
- Net Debt increased by $214 mln over the past reporting period (155.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 176.1% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went up +14.3% vs S&P500 +0.5%

------------------------------------------------

2025-08-09

#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191058)
(2025-08-08, Before Market Open):

- Revenue 0% YoY (vs -5.9% in previous quarter and historical rate +6.1%)
- EV/Sales multiple is 0x

At the opening of the session the share price went up +3.1% vs S&P500 +0.2%

------------------------------------------------

2025-08-09

#reports #EEFT

[Euronet Worldwide](https://eninvs.com/all.php?name=EEFT) (Financial services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=190892)
(2025-07-31, After Market Close):

- Revenue +8.9% YoY (vs +6.9% in previous quarter and historical rate +9.0%)
- EBITDA +14.3% YoY (vs +10.3% in previous quarter and historical rate +18.5%)
- EBITDA margin 17.9% increased compared to 17.0% same period last year
- Net Debt increased by $319 mln over the past reporting period (8.0% of market cap)
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went down -1.2% vs S&P500 -0.8%

Switch to company model in classical logic    *